Foghorn Therapeutics Competitors and Similar CompaniesClear all

Foghorn Therapeutics's competitors and similar companies include Nurix Therapeutics, Kymera Therapeutics and Ultivue.

	Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.	Nurix Therapeutics Nurix Therapeutics is a clinical-stage biopharmaceutical company.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.	Ultivue Ultivue operates in the biotechnology industry.
Founding Date	Founding Date 2016	Founding Date 2012	Founding Date 2017	Founding Date 2015
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech chemicals
Locations	Locations Cambridge, US HQ Cambridge, US	Locations San Francisco, US HQ	Locations Watertown, US HQ Cambridge, US	Locations Cambridge, US HQ Segrate, IT
Employees	Employees 1123% decrease	Employees 3344% increase	Employees 207	Employees 432% decrease
Valuation ($)	Valuation ($) 452 m	Valuation ($) N/A	Valuation ($) 3.1 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $30.9m (FY, 2025)	Revenue (est.) $84m (FY, 2025)	Revenue (est.) $39.2m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($74.4m) (FY, 2025)	Net income ($264.5m) (FY, 2025)	Net income ($311.4m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 50m	Total funding raised $ 165.2m	Total funding raised $ 197m	Total funding raised $ 57.3m